NEALKOHOLNI STEATOHEPATITIS PRI OTROKU − PRAKTIČNI PRISTOP S PREDSTAVITVIJO PRIMERA

QR Code

NEALKOHOLNI STEATOHEPATITIS PRI OTROKU − PRAKTIČNI PRISTOP S PREDSTAVITVIJO PRIMERA

Nealkoholna maščobna spremenjenost jeter pri otrocih je kronična bolezen jeter, ki nastane zaradi kopičenja maščob v jetrih. Tesno je povezana z debelostjo in nekaterimi drugimi dejavniki tveganja. Njena pogostost se v razvitem svetu v zadnjih letih strmo povečuje, predvsem na račun naraščajočega št...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ana Šinkovec, Milanka Živanović, Martin Thaler, Jernej Brecelj
Format:	article
Langue:	SL
Publié:	The Society for Children with Metabolic Disorders 2021
Sujets:	otrok nealkoholni steatohepatitis nealko-holna maščobna spremenjenost jeter priporočila Medicine R Pediatrics RJ1-570
Accès en ligne:	https://doaj.org/article/5d81b0d644174279b3d7fdd89ccda062
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
par: Ana Šinkovec, et autres
Publié: (2021)

A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
par: Liao Shenling, et autres
Publié: (2021)

Obesidad: factor de riesgo para esteatohepatitis y fibrosis hepática
par: Poniachik T,Jaime, et autres
Publié: (2002)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
par: Sadatsugu Sakane, et autres
Publié: (2021)

Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
par: VARELA,NELSON M, et autres
Publié: (2008)

Circulatory <i>Endothelin 1-</i>Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study
par: Reda Albadawy, et autres
Publié: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
par: T. E. Promenasheva, et autres
Publié: (2014)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
par: Na Fei, et autres
Publié: (2020)

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
par: Hegazy MA, et autres
Publié: (2020)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
par: Filip R, et autres
Publié: (2018)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
par: Apollinariya V. Bogolyubova, et autres
Publié: (2017)

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary
par: Feixue Wang, et autres
Publié: (2022)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
par: Takemi Akahane, et autres
Publié: (2021)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
par: Kaitlin Day, et autres
Publié: (2021)

Current and Potential Therapies Targeting Inflammation in NASH
par: Somaya Albhaisi, et autres
Publié: (2021)

First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study
par: Shigeo Shimose, et autres
Publié: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
par: Mao YQ, et autres
Publié: (2016)

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
par: Hegazy M, et autres
Publié: (2020)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9Summary
par: Robim M. Rodrigues, et autres
Publié: (2022)

Editorial: New Insights Into Understanding and Managing NAFLD
par: Óscar Escribano, et autres
Publié: (2021)

Chlorogenic Acid Protects against Advanced Alcoholic Steatohepatitis in Rats via Modulation of Redox Homeostasis, Inflammation, and Lipogenesis
par: Vyacheslav Buko, et autres
Publié: (2021)

Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity
par: Xin Xin, et autres
Publié: (2021)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
par: Masahiro Matsui, et autres
Publié: (2021)

Participativni pristop pri pripravi upravljavskih načrtov na primeru izbranih gozdnih habitatnih tipov in živalskih vrst ob Muri
par: Andreja Ferreira, et autres
Publié: (2021)

Biochemical assessment of metabolic associated fatty liver disease
par: Guerra-Ruiz Armando R., et autres
Publié: (2021)

The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
par: Mai BH, et autres
Publié: (2019)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
par: Ekaterina E. Mishina, et autres
Publié: (2017)

Association of insulin resistance and non-alcoholic fatty liver disease
par: Ekaterina E. Mishina, et autres
Publié: (2021)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
par: A. V. Bogolyubova, et autres
Publié: (2019)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
par: Aleksandr I. Pavlov, et autres
Publié: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
par: Sarwar R, et autres
Publié: (2018)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
par: Shahinul Alam, et autres
Publié: (2021)

Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis
par: Peter M. Abuja, et autres
Publié: (2021)

Low-dose LPS promotes progress of non-alcoholic steatohepatitis by up-regulating TLR4 in macrophages
par: YU Yang, et autres
Publié: (2021)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
par: Mahamid M, et autres
Publié: (2018)

Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
par: Yu HH, et autres
Publié: (2019)

Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
par: Diaz Soto MP, et autres
Publié: (2020)

Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
par: Fangli Zhou, et autres
Publié: (2021)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
par: Lauszus JS, et autres
Publié: (2021)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)